Daunorubicin Versus Mitoxantrone Versus Idarubicin As Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10
AUTOR(ES)
Mandelli, Franco
FONTE
American Society of Clinical Oncology
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2773224Documentos Relacionados
- Conventional chemotherapy for acute myeloid leukemia: a Brazilian experience
- Bone marrow transplantation and acute myeloid leukemia: Brazilian guidelines
- Possible benefit of consolidation therapy with high-dose cytarabine on overall survival of adults with non-promyelocytic acute myeloid leukemia
- Acute lymphoblastic leukemia to acute myeloid leukemia: an unusual case report of lineage switching
- Current treatment preferences in acute myeloid leukemia: a survey in Brazil